單篇文章 No.
17
-----
NIH Ivermectin|COVID-19 Treatment Guidelines
Last Updated:
February 11, 2021
Rationale
Ivermectin has been shown to inhibit the replication of SARS-CoV-2 in cell cultures.
However, pharmacokinetic and pharmacodynamic studies suggest that achieving the plasma concentrations necessary for the antiviral efficacy detected in vitro would require administration of doses up to 100-fold higher than those approved for use in humans.
---
艾弗姆通已被證明能抑制SARS-CoV-2在細胞培養中的複製。然而，藥動力學和藥理動力學研究表明，要達到體外檢測到的抗病毒功效所需的血漿濃度，
需要的劑量比批准用於人類的劑量高100倍。
引用:
|
作者moronNZ
ptt/udn根本是加油添醋。。那訪談裡就有只有說道他透漏有寫給FDA建議使用伊維菌素，但FDA回給他要做的讓人直接就放棄。他就和另外兩個說老藥新用的阻力是很大。醫師醫院的阻力也很大。他在訪談為一批評的就是"叫人回家等到缺氧"和"缺乏公開資訊和討論".....給人連結就是自己去看去聽自己做決定。
|